Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Amsterdam UMC

Amsterdam UMC in Amsterdam, Netherlands is listed as a site for 200 registered clinical trials, 125 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 200
Ongoing 125

This page covers the site record Amsterdam UMC in Amsterdam, Netherlands: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Amsterdam UMC report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 200 trials counted.

  • Phase 1 6 trials
  • Phase 1/2 11 trials
  • Phase 2 16 trials
  • Phase 2/3 5 trials
  • Phase 3 25 trials
  • Phase 4 15 trials
  • Not applicable 69 trials
  • Observational 53 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 125 trials
  • Completed 46 trials
  • Terminated 12 trials
  • Other 17 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 36

2009: 1 trials (Observational 1) 2014: 3 trials (Observational 1, Not applicable 1, Phase 2 1) 2015: 1 trials (Observational 1) 2016: 1 trials (Phase 1/2 1) 2017: 3 trials (Observational 1, Not applicable 2) 2018: 7 trials (Observational 4, Not applicable 1, Phase 4 1, Phase 2/3 1) 2019: 11 trials (Observational 3, Not applicable 2, Phase 4 1, Phase 3 1, Phase 2 3, Phase 1/2 1) 2020: 20 trials (Observational 5, Not applicable 2, Phase 4 1, Phase 3 4, Phase 2 3, Phase 1/2 4, Phase 1 1) 2021: 22 trials (Observational 5, Not applicable 10, Phase 3 5, Phase 2/3 1, Phase 2 1) 2022: 16 trials (Observational 2, Not applicable 6, Phase 4 1, Phase 3 2, Phase 2 2, Phase 1/2 2, Phase 1 1) 2023: 31 trials (Observational 8, Not applicable 7, Phase 4 7, Phase 3 4, Phase 2 1, Phase 1/2 3, Phase 1 1) 2024: 31 trials (Observational 11, Not applicable 10, Phase 4 1, Phase 3 6, Phase 2/3 1, Phase 2 1, Phase 1 1) 2025: 36 trials (Observational 9, Not applicable 18, Phase 4 2, Phase 3 2, Phase 2/3 2, Phase 2 2, Phase 1 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 17
2025 36
2024 31
2023 31
2022 16
2021 22
2020 20
2019 11
2018 7
2017 3

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.